envelope external link

Publications

  • A quantitative view of strategies to engineer cell-selective ligand binding. Z. C. Tan, B. T. Orcutt-Jahns, & A. S. Meyer. (2021). Integrative Biology (Accepted). [Abstract] [Preprint]
  • Integrated proteomics-based physical and functional mapping of AXL kinase signaling pathways and inhibitors define its role in cell migration . A. Majumder, S. Hosseinian, M. J. Stroud, E. Adhikari, J. J. Saller, D. M. A. Smith, D. G. Zhang, S. Agarwal, M. Creixell, B. S. Meyer, M. F. Kinose, K. S. Bowers, B. Fang, P. A. Stewart, E. A. Welsh, T. A. Boyle, A. Meyer, J. M. Koomen, & E. B. Haura. (2021). Molecular Cancer Research (Accepted). [Abstract]
  • Tensor-structured decomposition improves systems serology analysis. Z. C. Tan, M. Murphy, H. S. Alpay, S. D. Taylor, & A. S. Meyer. (2021). Molecular Systems Biology. [Abstract] [DOI] [Preprint]
  • Multivalency enhances the specificity of Fc-cytokine fusions. B. Orcutt-Jahns, P. C. Emmel, E. M. Snyder, C. Posner, S. M. Carlson, & A. S. Meyer. (2021). Submitted. [Abstract] [Preprint]
  • A lineage tree-based hidden Markov model to quantify cellular heterogeneity and plasticity. F. Mohammadi, S. Visagan, S. M. Gross, L. Karginov, J. C. Lagarde, L. M. Heiser, & A. S. Meyer. (2021). Submitted. [Abstract] [Preprint]
  • Motif-based phosphoproteome clustering improves modeling and interpretation. M. Creixell, & A. S. Meyer. (2021). Submitted. [Abstract] [Preprint]
  • Modeling Cell-Specific Dynamics and Regulation of the Common Gamma Chain Cytokines. A. M. Farhat, A. C. Weiner, C. Posner, Z. S. Kim, S. M. Carlson, & A. S. Meyer. (2021). Cell Reports. [Abstract] [DOI] [Preprint]
  • Analysis and modeling of cancer drug responses using cell cycle phase-specific rate effects. S. M. Gross, F. Mohammadi, C. Sanchez-Aguila, P. J. Zhan, A. S. Meyer, & L. M. Heiser. (2021). BioRxiv. [Abstract] [DOI] [Preprint]
  • A general model of multivalent binding with ligands of heterotypic subunits and multiple surface receptors . Z. C. Tan, & A. S. Meyer. (2021). Mathematical Biosciences. [Abstract] [DOI] [Preprint]
  • Measurement and models accounting for cell death capture hidden variation in compound response. S. Y. Bae, N. Guan, R. Yan, K. Warner, S. D. Taylor, & A. S. Meyer. (2020). Cell Death & Disease. [Abstract] [DOI] [Preprint]
  • An engineered human Fc domain that behaves like a pH-toggle switch for ultra-long circulation persistence . C.-H. Lee, T. H. Kang, O. Godon, M. Watanabe, G. Delidakis, C. M. Gillis, D. Sterlin, D. Hardy, M. Cogné, L. E. Macdonald, A. J. Murphy, N. Tu, J. Lee, J. R. McDaniel, E. Makowski, P. M. Tessier, A. S. Meyer, P. Bruhns, & G. Georgiou. (2019). Nature Communications. [Abstract] [DOI]
  • Systems biology approaches to measure and model phenotypic heterogeneity in cancer. A. S. Meyer, & L. M. Heiser. (2019). Current Opinion in Systems Biology. [Abstract] [DOI]
  • Versatile targeting system for lentiviral vectors involving biotinylated targeting molecules. K. Situ, B. A. Chua, S. Y. Bae, A. S. Meyer, & K. Morizono. (2018). Virology. [Abstract] [DOI]
  • Systems Modeling Identifies Divergent Receptor Tyrosine Kinase Reprogramming to MAPK Pathway Inhibition . A. M. Claas, L. Atta, S. Gordonov, A. S. Meyer, & D. A. Lauffenburger. (2018). Cellular and Molecular Bioengineering. [Abstract] [DOI]
  • Human induced pluripotent stem cell-derived glial cells and neural progenitors display divergent responses to Zika and dengue infections . J. Muffat, Y. Li, A. Omer, A. Durbin, I. Bosch, G. Bakiasi, E. Richards, A. Meyer, L. Gehrke, & R. Jaenisch. (2018). Proceedings of the National Academy of Sciences. [Abstract] [DOI]
  • Dissecting FcγR Regulation Through a Multivalent Binding Model. R. A. Robinett, N. Guan, A. Lux, M. Biburger, F. Nimmerjahn, & A. S. Meyer. (2018). Cell Systems. [Abstract] [DOI]
  • Apoptotic Bodies Elicit Gas6-mediated Migration of AXL-expressing Tumor Cells. A. Zweemer, C. B. French, J. Mesfin, S. Gordonov, A. S. Meyer, & D. A. Lauffenburger. (2017). Molecular Cancer Research. [Abstract] [DOI]
  • A Biomaterial Screening Approach to Reveal Microenvironmental Mechanisms of Drug Resistance. A. D. Schwartz, L. E. Barney, L. E. Jansen, T. V. Nguyen, C. L. Hall, A. S. Meyer, & S. Peyton. (2017). Integrative Biology. [Abstract] [DOI]
  • Systems Approaches to Cancer Biology. T. C. Archer, E. J. Fertig, S. J. C. Gosline, M. Hafner, S. K. Hughes, B. A. Joughin, A. S. Meyer, S. R. Piccolo, & A. N. Shajahan-Haq. (2016). Cancer Research. [Abstract] [DOI]
  • JNK Pathway Activation Modulates Acquired Resistance to EGFR/HER2-Targeted Therapies. S. Manole, E. J. Richards, & A. S. Meyer. (2016). Cancer Research. [Abstract] [DOI]
  • Reduced Proteolytic Shedding of Receptor Tyrosine Kinases Is a Post-Translational Mechanism of Kinase Inhibitor Resistance . M. A. Miller, M. J. Oudin, R. J. Sullivan, S. J. Wang, A. S. Meyer, H. Im, D. T. Frederick, J. Tadros, L. G. Griffith, H. Lee, R. Weissleder, K. T. Flaherty, F. B. Gertler, & D. A. Lauffenburger. (2016). Cancer Discovery. [Abstract] [DOI]
  • A requirement for filopodia extension toward Slit during Robo-mediated axon repulsion. R. E. McConnell, J. E. V. Veen, M. Vidaki, A. V. Kwiatkowski, A. S. Meyer, & F. B. Gertler. (2016). Journal of Cell Biology. [Abstract] [DOI]
  • Selectivity in Subunit Composition of Ena/VASP Tetramers. D. N. Riquelme, A. S. Meyer, M. Barzik, A. Keating, & F. Gertler. (2015). Bioscience Reports. [Abstract] [DOI]
  • Targeting autocrine HB-EGF signaling with specific ADAM12 inhibition using recombinant ADAM12 prodomain . M. A. Miller, M. L. Moss, G. Powell, R. Petrovich, L. Edwards, A. S. Meyer, L. G. Griffith, & D. A. Lauffenburger. (2015). Scientific Reports. [Abstract]
  • The AXL Receptor Is a Sensor of Ligand Spatial Heterogeneity. A. S. Meyer, A. J. M. Zweemer, & D. A. Lauffenburger. (2015). Cell Systems. doi: 10.1016/j.cels.2015.06.002 [Abstract] [DOI]
  • The Receptor AXL Diversifies EGFR Signaling and Limits the Response to EGFR-Targeted Inhibitors in Triple-Negative Breast Cancer Cells . A. S. Meyer, M. A. Miller, F. B. Gertler, & D. A. Lauffenburger. (2013). Science Signaling. [Abstract] [DOI]
  • ADAM-10 and -17 regulate endometriotic cell migration via concerted ligand and receptor shedding feedback on kinase signaling. . M. A. Miller, A. S. Meyer, M. T. Beste, Z. Lasisi, S. Reddy, K. W. Jeng, C.-H. Chen, J. Han, K. Isaacson, L. G. Griffith, & D. A. Lauffenburger. (2013). Proc Natl Acad Sci U S A. [Abstract] [DOI]
  • 2D protrusion but not motility predicts growth factor–induced cancer cell migration in 3D collagen . A. S. Meyer, S. K. Hughes-Alford, J. E. Kay, A. Castillo, A. Wells, F. B. Gertler, & D. A. Lauffenburger. (2012). The Journal of Cell Biology. [Abstract] [DOI]
  • Fluorinert, an oxygen carrier, improves cell culture performance in deep square 96-well plates by facilitating oxygen transfer . A. Meyer, R. G. G. Condon, G. Keil, N. Jhaveri, Z. Liu, & Y.-S. Tsao. (2012). Biotechnology Progress. [Abstract] [DOI]
  • Signaling network state predicts Twist-mediated effects on breast cell migration across diverse growth factor contexts . H.-D. Kim, A. S. Meyer, J. P. Wagner, S. K. Alford, A. Wells, F. B. Gertler, & D. A. Lauffenburger. (2011). Molecular & Cellular Proteomics. [Abstract] [DOI]
  • Integrated Pathway Analysis of Genome-Wide Expression Changes Associated with Serum-Free Suspension Adaptation of an Antibody-Producing Chinese Hamster Ovary (CHO) Cell Line . Y.-S. Tsao, A. A. Merchant, A. Meyer, Z. Liu, M. Smith, D. Levitan, & E. Gustafson. (2010). In Animal Cell Technology: Basic & Applied Aspects. [DOI]
  • Concentration of mammalian genomic DNA using two-phase aqueous micellar systems. F. Mashayekhi, A. S. Meyer, S. A. Shiigi, V. Nguyen, & D. T. Kamei. (2009). Biotechnology and Bioengineering. [Abstract] [DOI]
  • Enhancing the Detection of Urinary Tract Infections Using Two-Phase Aqueous Micellar Systems. S. A. Shiigi, A. S. Meyer, & D. T. Kamei. (2009). The UCLA USJ. [Abstract]